SCHEMBL31421097

SCHEMBL31421097

CC(C)(C)OC(=O)N1CCCC[C@@H](COS(C)(=O)=O)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.50
HPGD P15428 1/20 0.46
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
BACE1 P56817 2/20 0.43
CTSD P07339 1/20 0.43
GLS O94925 2/20 0.42
EPHX1 P07099 1/20 0.41
PDE4B Q07343 1/20 0.41
GPR119 Q8TDV5 3/20 0.41
ACKR3 P25106 1/20 0.41
NR1H2 P55055 1/20 0.41
KAT6A Q92794 1/20 0.40
KAT5 Q92993 1/20 0.40
KAT7 O95251 1/20 0.40
KAT8 Q9H7Z6 1/20 0.40
ALOX5AP P20292 1/20 0.40
FEN1 P39748 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31420855 1.00 SCN9A (0.50) SCN9AHPGDMEN1ALDH1A1MAPT
SCHEMBL1785143 0.96 SCN9A (0.53) SCN9AHPGDMEN1ALDH1A1MAPT
SCHEMBL1785144 0.96 SCN9A (0.53) SCN9AHPGDMEN1ALDH1A1MAPT
SCHEMBL2955344 0.96 SCN9A (0.53) SCN9AHPGDMEN1ALDH1A1MAPT
SCHEMBL624013 0.94 SCN9A (0.54) SCN9AHPGDMEN1ALDH1A1MAPT
SCHEMBL3713816 0.94 SCN9A (0.52) SCN9AHPGDMEN1ALDH1A1MAPT
SCHEMBL707476 0.91 SCN9A (0.50) SCN9AHPGDMEN1ALDH1A1MAPT
SCHEMBL2241775 0.91 GPR119 (0.47) SCN9AHPGDMEN1ALDH1A1MAPT
SCHEMBL613607 0.91 GPR119 (0.47) SCN9AHPGDMEN1ALDH1A1MAPT
SCHEMBL613606 0.91 GPR119 (0.47) SCN9AHPGDMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-04-24 US disclosed
WO-2025064718-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, NRAS SCN9A 2730/4885HPGD 2011/4885MEN1 798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.